Current Report Filing (8-k)
October 15 2013 - 7:59AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
|
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Date of report (Date of
earliest event reported): October 4, 2013
Applied DNA Sciences, Inc.
(Exact Name of Registrant
as Specified in Charter)
Delaware
(State or Other Jurisdiction
of Incorporation) |
002-90539
(Commission File Number) |
59-2262718
(IRS Employer
Identification No.) |
50 Health Sciences Drive
Stony Brook, New York 11790
(Address of Principal Executive
Offices) (Zip Code)
631-240-8800
(Registrant’s telephone
number, including area code)
Not Applicable
(Former Name or Former Address,
if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation
of the registrant under any of the following provisions (see General Instruction A.2 below):
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 40.14d - (b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e - (c)) |
On October 4, 2013, Applied DNA Sciences, Inc.,
as seller (the “Seller”), entered into a master option agreement with one of the four largest American Defense Contractors,
as buyer (“Buyer”), and committed to supply one (1) unique SigNature® DNA provenance mark for Buyer and SigNature®
DNA ink for marking up to 25,000 electronic components/year, upon Buyer’s request through the issuance of a purchase order
(“Goods”). For the Buyer, the agreement is an enterprise-wide option to purchase. The term of the agreement commenced
on October 3, 2013 and expires October 3, 2023. Buyer has engaged a third-party marker, which third-party marker is and must remain
approved by Seller, to provide certain services to incorporate Seller’s ink onto certain electronic components of Buyer.
Either party may terminate the agreement in the event of a material breach that is uncured for 30 days. Seller has received from
Buyer one purchase order governed by these terms in the amount of $62,000 thus far. The agreement severely restricts publicity
on behalf of both parties.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
Applied DNA Sciences, Inc. |
|
(Registrant) |
|
By: |
/s/ James A. Hayward |
|
|
|
James A. Hayward |
|
|
Chief Executive Officer |
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024